Provectus Biopharmaceuticals, Inc. (PVCT) SEC News Oct. 24, 2025, 20:48 UTC 0 1 comments Director Pershing Edward 🟢 acquired 7.0K shares (1 derivative) of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) at $2.86 Transaction Date: Oct 23, 2025 | Filing ID: 019326 Comment Full text
AcelRx Pharmaceuticals Inc (Rebranding to Talphera, Inc.) (ACRX) SEC News Oct. 24, 2025, 20:48 UTC 0 1 comments Bozilenko Marina 🟢 acquired 29.9K shares (1 derivative) of TALPHERA, INC. (TLPH) at $1.14 Transaction Date: Oct 23, 2025 | Filing ID: 000005 Comment Full text
AcelRx Pharmaceuticals Inc (Rebranding to Talphera, Inc.) (ACRX) SEC News Oct. 24, 2025, 20:46 UTC 0 1 comments Broadfoot Jill Marie 🟢 acquired 29.9K shares (1 derivative) of TALPHERA, INC. (TLPH) at $1.14 Transaction Date: Oct 23, 2025 | Filing ID: 000004 Comment Full text
AcelRx Pharmaceuticals Inc (Rebranding to Talphera, Inc.) (ACRX) SEC News Oct. 24, 2025, 20:45 UTC 0 1 comments ADAMS ADRIAN 🟢 acquired 29.9K shares (1 derivative) of TALPHERA, INC. (TLPH) at $1.14 Transaction Date: Oct 23, 2025 | Filing ID: 000004 Comment Full text
AcelRx Pharmaceuticals Inc (Rebranding to Talphera, Inc.) (ACRX) SEC News Oct. 24, 2025, 20:41 UTC 0 1 comments JAIN ABHINAV 🟢 acquired 29.9K shares (1 derivative) of TALPHERA, INC. (TLPH) at $1.14 Transaction Date: Oct 23, 2025 | Filing ID: 000006 Comment Full text
Syndax Pharmaceuticals Inc (SNDX) SEC News Oct. 24, 2025, 20:40 UTC 0 1 comments (90% Positive) SYNDAX PHARMACEUTICALS, INC. (SNDX) Announces Enrollment Update for translocation Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Silo Pharma Inc (SILO) SEC News Oct. 24, 2025, 20:39 UTC 0 1 comments (99% Neutral) Silo Pharma, Inc. (SILO) Announces Executive Changes Comment Full text
Immunovant Inc (IMVT) SEC News Oct. 24, 2025, 20:38 UTC 0 1 comments Geffner Michael 🔴 sold 2.6K shares of Immunovant, Inc. (IMVT) at $19.03 Transaction Date: Oct 22, 2025 | Filing ID: 000144 Comment Full text
NextCure Inc (NXTC) SEC News Oct. 24, 2025, 20:38 UTC 0 0 comments New Form SCHEDULE 13G - NextCure, Inc. Filed: 2025-10-24 AccNo: 0002050709-25-000009 Size: 80 KB Comment Full text
Immunovant Inc (IMVT) SEC News Oct. 24, 2025, 20:36 UTC 0 1 comments Stout Jay S 🔴 sold 2.5K shares of Immunovant, Inc. (IMVT) at $19.03 Transaction Date: Oct 22, 2025 | Filing ID: 000143 Comment Full text